Apatinib for Extensive Stage Small Cell Lung Cancer After Second/Third Line Chemotherapy.

NCT02945852 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fan Yun, MD